Home › Immunoblastic Lymphadenopathy › Florida › Miami
Immunoblastic Lymphadenopathy clinical trials in Miami, FL
4 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
RecruitingPhase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine, Miami
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
RecruitingPhase 1
- Clinical Trial Site, Miami
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- University of Miami (Data Collection Only), Miami
Immunoblastic Lymphadenopathy trials in other cities
- New York City, NY5 studies
- Houston, TX4 studies
- Chicago, IL4 studies
- Durham, NC4 studies
- Ann Arbor, MI3 studies
- Baldwin Park, CA3 studies
- New Haven, CT3 studies
- Edison, NJ3 studies
- Boston, MA3 studies
- Columbus, OH3 studies
- Rochester, MN3 studies
- Atlanta, GA3 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Prostate Cancer30 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.